NEW YORK, Sept. 6 – BioBridge Computing has finished developing its PIUMS protein identification software and has delivered the first unit to its research partner AstraZeneca, GenomeWeb has learned.
PIUMS—or Protein Identification Using Mass Spectrometry—is a fully automated software that includes Pepex, BioBridge’s peak extraction software. The two companies have been developing the software since they first struck a deal in July to develop the product.
A spokesperson for Lund, Sweden-based BioBridge said that the PIUMS software will be launched around November and cost roughly $10,000.
“By developing a new improved scoring algorithm to existing alternatives and a reliable method for validation we have created a very fast database search tool with very high reliability,” said Jim Samuelson, who co-led the project for BioBridge.